Document is current
Any future updates will be listed below
-
Authors
Nedeljkovic, Ivana https://orcid.org/0000-0002-0370-1473
Carnero-Montoro, Elena
Lahousse, Lies
van der Plaat, Diana A.
de Jong, Kim
Vonk, Judith M.
van Diemen, Cleo C.
Faiz, Alen
van den Berge, Maarten
Obeidat, Ma’en
Bossé, Yohan https://orcid.org/0000-0002-3067-3711
Nickle, David C.
Consortium, BIOS
Uitterlinden, Andre G.
van Meurs, Joyce J. B.
Stricker, Bruno C. H.
Brusselle, Guy G.
Postma, Dirkje S.
Boezen, H. Marike
van Duijn, Cornelia M.
Amin, Najaf
- License Information
-
More Information
Article History
Received: 14 March 2017
Revised: 6 November 2017
Accepted: 19 December 2017
First Online: 8 February 2018
Compliance with ethical standards
:
: LL reports personal fees from Boehringer Ingelheim GmbH, non-financial support from Novartis, grants from AstraZeneca, grants and non-financial support from European Respiratory Society, grants and non-financial support from Belgian Respiratory Society, outside the submitted work. MvdB reports research grants paid to The University from Chiesi, GlaxoSmithKline (GSK), Astra Zeneca and TEVA, outside the submitted work. DCN is employed by Merck & Co. The University of Groningen has received money for Professor D. Postma regarding a grant for research from Astra Zeneca, Chiesi, Genentec, GSK and Roche. Fees for consultancies were given to the University of Groningen by Astra Zeneca, Boehringer Ingelheim, Chiesi, GSK, Takeda and TEVA. The other authors declare that they have no conflict of interest.
